LEO Pharma Inc. Recalls

1 recall found for LEO Pharma Inc.. Check if any of your products are affected.

HIGHFDA DRUG

LEO Pharma Recalls Adbry Injection Over Sterility Concerns

LEO Pharma Inc. recalled 11,407 units of Adbry injection on February 10, 2026. The recall stems from a lack of assurance of sterility due to particulate matter identified as wool fiber. Consumers should stop using the product immediately and contact their healthcare provider for guidance.

ADBRY
Lack of
Read more

Brand Statistics

Total Recalls
1
Pages
1

Related Brands

ADBRY